What sector is EXEL in?

EXEL (EXEL) operates in the Healthcare sector, specifically in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) industry.

What is EXEL's market cap?

EXEL (EXEL) has a market capitalization of $11.41B.

How can I analyze EXEL stock?

Valhalla provides comprehensive analysis for EXEL including institutional trade flow, dark pool activity, options data, technical indicators, and proprietary scoring. Visit valhalla-labs.io/stocks/EXEL for a full breakdown.

Where can I find institutional trades for EXEL?

Valhalla tracks real-time institutional trade flow for EXEL, including dark pool blocks, lit block trades, and sweep orders. These insights help identify where smart money is positioned.

EXEL

Q: What is EXEL (EXEL)?

EXEL (EXEL) is a healthcare company in the biological products, (no diagnostic substances) industry. Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medu

Healthcare — BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

Valhalla Score 74

$43.67

Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.

Latest News

Exelixis (EXEL) Earnings Expected to Grow: What to Know Ahead of Next Week's ReleaseExelixis (EXEL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations....zacks.com — Apr 28, 2026

EXEL Data Insights

Dark pool activity detected in the last 5 trading days

Subscribe for full dark pool analysis, institutional flow, and real-time alerts.

📊 Key Statistics

Market Cap$11.41B

P/E Ratio—

EPS (TTM)—

EPS YoY—

Revenue YoY—

Float—

Short Float %—

Inst. Ownership—

Sector RS—

📈 Fundamentals

ROE—

ROIC—

ROA—

Current Ratio—

Debt/Equity—

Gross Margin—

Net Margin—

Dividend Yield—

Next Earnings—

⚡ Options Summary

Call OI—

Put OI—

P/C Ratio (OI)—

Gamma Environment—

Max Pain—

Call Wall—

Put Wall—

🎯 Analyst Estimates

Consensus Target—

High Target—

Low Target—

Analysts—

Upside/Downside—

📋 Quarterly Financials

Period	Revenue	Rev YoY	EPS	EPS YoY	Gross Margin

Start Free Trial See full options flow, dark pool data & more

🔥 Recent Options Flow

Type	Strike	Exp	Size	Premium	Time

Start Free Trial Institutional trades, dark pool vs lit exchange

🏛️ Institutional Trades

Type	Price	Size	Value	Venue	Time

Start Free Trial Full insider & congressional trade history

👤 Insider Trades

Name	Type	Shares	Price	Date

Start Free Trial Top institutional holders & ownership data

🏦 Top Institutional Holders

Institution	Shares	Value	% of Class